Catalog Number ENC452212 |
Device Problems
Premature Activation (1484); Failure to Advance (2524)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/29/2024 |
Event Type
malfunction
|
Event Description
|
As reported by the field, during an endovascular embolization to the right posterior communicating artery, an eu 4.5x22mm stent 12 mm dw tip intracranial stent (enc452212, 8470635) became impeded in distal end of a prowler select plus 150/5cm microcatheter (606s255x, 31075895) and could not pass through the microcatheter (mc).The physician retracted the stent and observed the stent body was separated prematurely from the delivery wire and the stent body was remained in the microcatheter.Then, the mc was removed from the patient.New devices were switched to complete the surgery.The procedure was prolonged about 20 minutes.No patient injury was reported.Additional event information was received on 08-mar-2024 indicating that there was no additional intervention needed to remove the devices from the patient.They were no able to torque the device.There was no evidence of physical material within the device.No other devices were successfully used with the concomitant device prior to the encountered resistance.The 20 minute procedural delay was not clinically significant.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section e1.Initial reporter phone: (b)(6).Section h3 - the device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This is one of two products involved with the complaint and the associated manufacturer report numbers are 3008114965-2024-00315 and 3008114965-2024-00316.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Updated sections on this medwatch: b4, d9, g3, g6, h2, h3, h6 and h10.Complaint conclusion: as reported by the field, during an endovascular embolization to the right posterior communicating artery, an eu 4.5x22mm stent 12 mm dw tip intracranial stent (enc452212, 8470635) became impeded in distal end of a prowler select plus 150/5cm microcatheter (606s255x, 31075895) and could not pass through the microcatheter (mc).The physician retracted the stent and observed the stent body was separated prematurely from the delivery wire and the stent body was remained in the microcatheter.Then, the mc was removed from the patient.New devices were switched to complete the surgery.The procedure was prolonged about 20 minutes.No patient injury was reported.Additional event information was received on 08-mar-2024 indicating that there was no additional intervention needed to remove the devices from the patient.They were no able to torque the device.There was no evidence of physical material within the device.No other devices were successfully used with the concomitant device prior to the encountered resistance.The 20-minute procedural delay was not clinically significant.A non-sterile eu 4.5x22mm stent 12 mm dw tip stent was received contained in the decontamination pouch.Upon receiving the device, a visual inspection was performed, and it was noted that the stent component was returned already detached from the delivery system.Microscopic inspection revealed that the delivery wire was broken and with one kinked condition.No damages were noted in the stent.The introducer was found to be undamaged (i.E., no kinks, bents o elongations).The delivery wire was subjected to dimensional analysis and all measurements were found to be within specification, including those specifications that control the attachment and delivery of the stent.Therefore, device failure is not suspected to be a contributing factor.The issue reported regarding the stent being impeded in the distal end of the microcatheter could not be evaluated through a functional test; the broken condition of the delivery wire prevents the ability to move forward the delivery system and perform the proper functional analysis.However, the reported issue can be confirmed based on such damage, which suggests that the device was subjected to certain manipulation in an attempt to overcome the difficulties experienced that could also have caused the stent detachment and the delivery wire to be broken during the withdrawal.Based on this, the complaint regarding a stent separated prematurely from the delivery wire was confirmed.There is no indication that the issue reported in the complaint is a result of a defect inherently related to the manufacture of the device.Lake region medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 8470635.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.As part of cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.Devices undergo 100% inspection at different points during the manufacturing process to prevent this type of damages from leaving the facility.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no capa activity is required.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) do contain the following recommendations: ¿ do not apply undue force if resistance is encountered at any point during stent manipulation.Withdraw the unit and advance to a new one.¿ if resistance is felt while recapturing the stent, do not continue to recapture the device.Withdraw the infusion catheter slightly to unsheathe the stent (without exceeding the recapture limit), and then attempt to recapture the stent again.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
|
|
Search Alerts/Recalls
|
|